Mendelian randomization for strengthening causal inference in observational studies: Application to gene × environment interactions

Perspectives on Psychological Science

Volumn 5, Issue 5, 2010, Pages 527-545

  Smith, George Davey ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Alcohol; Causal inference; Confounding; Epidemiology; Gene Envrionment interactions; Mendelian randomization

Indexed keywords

EID: 78149383523     PISSN: 17456916     EISSN: 17456924     Source Type: Journal    
DOI: 10.1177/1745691610383505     Document Type: Article

References (94)

1. Abrams, D.B. (2002). President's message. Quarterly Newsletter of the Society of Behavioral Medicine, pp. 1-2, 7, 15. Retrieved from http://www.sbm.org/outlook/02_03_Winter.pdf
2. Baird, P. (2000). Genetic technologies and achieving health for populations. International Journal of Health Services, 30, 407-424.
3. Berkowitz, A. (1996). Our genes, ourselves? Bioscience, 46, 42-51.
4. Beulens, J.W.J., Rimm, E.B., Ascherio, A., Spiegelman, D., Hendriks, H.F.J., & Mukamal, K.J. (2007). Alcohol consumption and risk for coronary heart disease among men with hypertension. Annals of Internal Medicine, 146, 10-19.
5. Birge, S.J., Keutmann, H.T., Cuatrecasas, P., & Wheedon, G.D. (1967). Osteoporosis, intestinal lactase deficiency and low dietary calcium intake. New England Journal of Medicine, 276, 445-448.
6. Boccia, S., Hashibe, M., Galli, P., De Feo, E., Asakage, T., Hashimoto, T., et al. (2009). Aldehyde dehydrogenase 2 and head and neck cancer: A meta-analysis implementing a Mendelian randomization approach. Cancer Epidemiology Biomarkers and Prevention, 18, 248-254.
7. Bovet, P., & Paccaud, F. (2001). Alcohol, coronary heart disease and public health: Which evidence-based policy? International Journal of Epidemiology, 30, 734-737.
8. Burd, L.J. (2006). Interventions in FASD: we must do better. Child Care Health Development, 33, 398-400.
9. Burr, M.L., Fehily, A.M., Butland, B.K., Bolton, C.H., & Eastham, R.D. (1986). Alcohol and high-density-lipoprotein cholesterol: A randomized controlled trial. British Journal of Nutrition, 56, 81-86.
10. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., et al. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301, 386-389.
11. Caspi, A., Williams, B., Kim-Cohen, J., Craig, I.W., Milne, B.J., Poulton, R., et al. (2007). Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proceedings of the National Academy of Sciences, USA, 104, 18860-18865.
12. Chao, Y.-C., Liou, S.-R., Chung, Y.-Y., Tang, H.-S., Hsu, C.-T., Li, T.-K., et al. (1994). Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology, 19, 360-366.
13. Chen, L., Davey Smith, G., Harbord, R., & Lewis, S. (2008). Alcohol intake and blood pressure: A systematic review implementing Mendelian randomization approach. PLoS Medicine, 461, 5.
14. Clayton, D., & McKeigue, P.M. (2001). Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet, 358, 1356-1360.
15. Darwin, C. (1876). The effects of cross and self fertilisation in the vegetable kingdom. London: John Murray.
16. Darwin, G.H. (1875). Marriages between first cousins and their effects. Journal of the Statistical Society of London, 38, 153-184.
17. Davey Smith, G. (2006a). Capitalising on Mendelian randomization to assess the effects of treatments. Retrieved from http://www.jameslindlibrary.org/trial_records/20th_Century/1990s/gray/graycommentary.html
18. Davey Smith, G. (2006b). Cochrane lecture: Randomised by (your) god-robust inference from an observational study design. Journal of Epidemiology and Community Health, 60, 382-388.
19. Davey Smith, G., & Ebrahim, S. (2003). Mendelian randomization: Can genetic epidemiology contribute to understanding environmental determinants of disease? International Journal of Epidemiology, 32, 1-22.
20. Davey Smith, G., & Ebrahim, S. (2004). Mendelian randomization: Prospects, potentials, and limitations. International Journal of Epidemiology, 33, 30-42.
21. Davey Smith, G., & Ebrahim, S. (2005). What can Mendelian randomization tell us about modifiable behavioural and environmental exposures. British Medical Journal, 330, 1076-1079.
22. Davey Smith, G., Ebrahim, S., Lewis, S., Hansell, A.L., Palmer, L.J., & Burton, P.J. (2005). Genetic epidemiology and public health: Hope, hype, and future prospects. Lancet, 366, 1484-1498.
23. Davey Smith, G., Harbord, R., Milton, J., Ebrahim, S., & Sterne, J.A.C. (2005). Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a metaanalysis of genetic association studies. Arteriosclerosis Thrombosis and Vascular Biology, 25, 2228-2233.
24. Davey Smith, G., Lawlor, D., Harbord, R., Timpson, N., Day, I., & Ebrahim, S. (2008). Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology. PLoS Medicine, 4, 1985-1992.
25. Davey Smith, G., Timpson, N., & Ebrahim, S. (2008). Strengthening causal inference in cardiovascular epidemiology through Mendelian randomization. Annals of Medicine, 12, 524-541.
26. Debat, V., & David, P. (2001). Mapping phenotypes: Canalization, plasticity and developmental stability. Trends in Ecology and Evolution, 16, 555-561.
27. Ebrahim, S., & Davey Smith, G. (2008). Mendelian randomization: Can genetic epidemiology help redress the failures of observational epidemiology? Human Genetics, 123, 15-33.
28. Enomoto, N., Takase, S., Yasuhara, M., & Takada, A. (1991). Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcoholism Clinical and Experimental Research, 15, 141-144.
29. Erichsen, H.C., Eck, P., Levine, M., & Chanock, S. (2001). Characterization of the genomic structure of the human vitamin C transporter SVCT1 (SLC23A2). Journal of Nutrition, 131, 2623-2627.
30. Fallon, U.B., Ben-Shlomo, Y., Elwood, P., Ubbink, J.B., & Davey Smith, G. (2001). Homocysteine and coronary heart disease: Author's reply. Retrieved from http://heart.bmjjournals.com/cgi/eletters/85/2/153
31. Fisher, R.A. (1952). Statistical methods in genetics. Heredity, 6, 1-2.
32. Freathy, R.M., Timpson, N.J., Lawlor, D.A., Pouta, A., Ben-Shlomo, Y., Ruokonen, A., et al. (2008). Common variation in the FTO gene alters diabetes-related metabolic traits to extent expected, given its effect on BMI. Diabetes, 57, 1419-1426.
33. Garcia-Closas, M., Malats, N., Silverman, D., Dosemeci, M., Kogevinas, M., Hein, D.W., et al. (2005). NAT2 slow acetylation, GSTM1null genotype, and risk of bladder cancer: Results from the Spanish Bladder Cancer Study and meta-analyses. Lancet, 366, 649-659.
34. Gemma, S., Vichi, S., & Testai, E. (2007). Metabolic and genetic factors contributing to alcohol induced effects and fetal alcohol syndrome. Neuroscience & Biobehavioral Reviews, 31, 221-229.
35. Gibson, G., & Wagner, G. (2000). Canalization in evolutionary genetics: A stabilizing theory? BioEssays, 22, 372-380.
36. Glebart, W.M. (1998). Databases in genomic research. Science, 282, 659-661.
37. Glynn, R.K. (2006). Commentary: Genes as instruments for evaluation of markers and causes. International Journal of Epidemiology, 35, 932-934.
38. Haldane, J.B.S. (1938). Heredity and politics. London: George Allen and Unwin.
39. Hart, C., Davey Smith, G., Hole, D., & Hawthorne, V. (1999). Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: Results from a prospective cohort study of Scottish men with 21 years of follow up. British Medical Journal, 318, 1725-1729.
40. Hartman, J.L., Garvik, B., & Hartwell, L. (2001). Principles for the buffering of genetic variation. Science, 291, 1001-1004.
41. Hashibe, M., McKay, J.D., Curado, M.P., Oliveira, J.C., Koifman, S., Koifman, R., et al. (2008). Multiple ADH genes are associated with upper aerodigestive cancers. Nature Genetics, 40, 707-709.
42. Hasin, D., Aharonovich, E., Liu, X., Mamman, Z., Matseoane, K., Carr, L., et al. (2002). Alcohol and ADH2 in Israel: Ashkenazis, Sephardics, and recent Russian immigrants. American Journal of Psychiatry, 159, 1432-1434.
43. Haskell, W.L., Camargo, C., Williams, P.T., Vranizan, K.M., Krauss, R.M., Lindgren, F.T., et al. (1984). The effect of cessation and resumption of moderate alcohol intake on serum high-densitylipoprotein subfractions. New England Journal of Medicine, 310, 805-810.
44. Higuchi, S., Matsuushitam, S., Imazeki, H., Kinoshita, T., Takagi, S., & Kono, H. (1994). Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet, 343, 741-742.
45. Holtzman, N.A. (2001). Putting the search for genes in perspective. International Journal of Health Services, 31, 445.
46. Honkanen, R., Pulkkinen, P., Järvinen, R., Kröger, H., Lindstedt, K., Tuppurainen, M., et al. (1996). Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women. Bone, 19, 23-28.
47. Hornstein, E., & Shomron, N. (2006). Canalization of development by microRNAs. Nature Genetics, 38, S20-S24.
48. Irons, D.E., McGue, M., Iacono, W.G., & Oetting, W.S. (2007). Mendelian randomization: A novel test of the gateway hypothesis and models of gene-environment interplay. Development and Psychopathology, 19, 1181-1195.
49. Jacobson, S.W., Carr, L.G., Croxford, J., Sokol, R.J., Li, T.K., & Jacobson, J.L. (2006). Protective effects of the alcohol dehydrogenase-ADH1B allele in children exposed to alcohol during pregnancy. Journal of Pediatrics, 148, 30-37.
50. Jousilahti, P., & Salomaa, V. (2004). Fibrinogen, social position, and Mendelian randomisation. Journal of Epidemiology and Community Health, 58, 883.
51. Kandel, D., & Yamaguchi, K. (1993). From beer to crack: Developmental patterns of drug involvement. American Journal of Public Health, 83, 851-855.
52. Kandel, D.B., Yamaguchi, K., & Chen, K. (1992). Stages of progression in drug involvement from adolescence to adulthood: Further evidence for the gateway theory. Journal of Studies on Alcohol, 53, 447-457.
53. Kaplan, J.M., & Pigliucci, M. (2001). Genes "for" phenotypes: A modern history view. Biology and Philosophy, 16, 189-213.
54. Keavney, B. (2002). Genetic epidemiological studies of coronary heart disease. International Journal of Epidemiology, 31, 730-736.
55. Kitami, T., & Nadeau, J.H. (2002). Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication. Nature Genetics, 32, 191-194.
56. Klatsky, A.L. (2001). Commentary: Could abstinence from alcohol be hazardous to your health? International Journal of Epidemiology, 30, 739-742.
57. Langlois, M.R., Delanghe, J.R., De Buyzere, M.L., Bernard, D.R., & Ouyang, J. (1997). Effect of haptoglobin on the metabolism of vitamin C. American Journal of Clinical Nutrition, 66, 606-610.
58. Lawlor, D.A., Harbord, R.M., Timpson, N.J., Lowe, G.D.O., Rumley, A., Gaunt, T.R., et al. (2008). The association of C-reactive protein and CRP genotype with coronary heart disease: Findings from five studies with 4,610 cases amongst 18,637 participants. PLoS One, 8, e3011.
59. Lewis, S., & Davey Smith, G. (2005). Alcohol, ALDH2 and esophageal cancer: A meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiology Biomarkers and Prevention, 14, 1967-1971.
60. Lower, G.M., Nilsson, T., Nelson, C.E., Wolf, H., Gamsky, T.E., & Bryan, G.T. (1979). N-acetylransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Environmental Health Perspectives, 29, 71-79.
61. Marmot, M. (2001). Reflections on alcohol and coronary heart disease. International Journal of Epidemiology, 30, 729-734.
62. Memik, F. (2003). Alcohol and esophageal cancer, is there an exaggerated accusation? Hepatogastroenterology, 54, 1953-1955.
63. Morgan, T.H. (1935). The relation of genetics to physiology and medicine. Scientific Monthly, 41, 5-18.
64. Newcomer, A.D., Hodgson, S.F., Douglas, M.D., & Thomas, P.J. (1978). Lactase deficiency: Prevalence in osteoporosis. Annals of Internal Medicine, 89, 218-220.
65. Osier, M.V., Pakstis, A.J., Soodyall, H., Comas, D., Goldman, D., Odunsi, A., et al. (2002). A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. American Journal of Human Genetics, 71, 84-99.
66. Ottman, R. (1990). An epidemiologic approach to gene-environment interaction. Genetic Epidemiology, 7, 177-185.
67. Ottman, R. (1996). Theoretical epidemiology: Gene-environmental interaction-Definitions and study designs. Preventive Medicine, 25, 764-770.
68. Ottman, R. (2006). Study design and analysis for assessment of interactions. In L. M. Hernandez and D. G. Blazer (Eds.), Genes, behavior, and the social environment: Moving beyond the nature/nurture debate (pp. 161-180). Washington, DC: National Academies Press.
69. Palmer, L., & Cardon, L. (2005). Shaking the tree: Mapping complex disease genes with linkage disequilibrium. Lancet, 366, 1223-1234.
70. Rimm, E. (2001). Commentary: Alcohol and coronary heart disease: Laying the foundation for future work. International Journal of Epidemiology, 30, 738-739.
71. Risch, N., Herrell, R., Lehner, T., Liang, K.-Y., Eaves, L., Hoh, J., et al. (2009). Interaction between the serotonin transporter gene (5- HTTLPR), stressful life events, and risk of depression. Journal of the American Medical Association, 301, 2462-2471.
72. Rutherford, S.L. (2000). From genotype to phenotype: Buffering mechanisms and the storage of genetic information. BioEssays, 22, 1095-1105.
73. Seitz, H.K., & Stickel, F. (2007). Molecular mechanisms of alcoholmediated carcinogenesis. Nature Reviews Cancer, 7, 599-612.
74. Shaper, A.G. (1993). Editorial: Alcohol, the heart, and health. American Journal of Public Health, 83, 799-801.
75. Steer, C.D., Davey Smith, G., Emmett, P.M., Hibbeln, J.R., & Golding, J. (in press). FADS2 polymorphisms modify the effect of breastfeeding on child IQ. PLoS 1.
76. Strohman, R.C. (1993). Ancient genomes, wise bodies, unhealthy people: The limits of a genetic paradigm in biology and medicine. Perspectives in Biology and Medicine, 37, 112-145.
77. Tabery, J.G. (2000). Causation in the nature-nurture debate: The case of genotype-environment interaction. Retrieved from http://etd.library.pitt.edu/ETD/available/etd-07232007-121636/unrestricted/Tabery-Causation%5B1%5D.in.the.Nature-Nurture.Debate.pdf
78. Tabery, J. (2007). Biometric and developmental gene-environment interactions: Looking back, moving forward. Development and Psychopathology, 19, 961-976.
79. Takagi, S., Iwai, N., Yamauchi, R., Kojima, S., Yasuno, S., Baba, T., et al. (2002). Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese men. Hypertension Research, 25, 677-681.
80. Terwilliger, J.D., & Weiss, W.M. (2003). Confounding, ascertainment bias, and the blind quest for a genetic "fountain of youth." Annals of Medicine, 35, 532-544.
81. Thomas, D.C., & Conti, D.V. (2004). Commentary on the concept of "Mendelian randomization." International Journal of Epidemiology, 33, 17-21.
82. Thompson, W.D. (1991). Effect modification and the limits of biological inference from epidemiological data. Journal of Clinical Epidemiology, 44, 221-232.
83. Timpson, N.J., Forouhi, N.G., Brion, M.J., Harbord, R.M., Cook, D.G., Johnson, P., et al. (2010). Genetic variation at the SCL23A1 locus is associated with circulating concentrations of L-ascorbic acid (Vitamin C): Evidence from 5 independent studies with >15,000 participants. American Journal of Clinical Nutrition, 92, 375-382.
84. Timpson, N.J., Lawlor, D.A., Harbord, R.M., Gaunt, T.R., Day, I.N.M., Palmer, L.J., et al. (2005). C-reactive protein and its role inmetabolic syndrome:Mendelian randomisation study. Lancet, 366, 1954-1959.
85. Timpson, N.J., Sayers, A., Davey Smith, G., & Tobias, J.H. (2009). How does body fat influence bone mass in childhood? A Mendelian randomisation approach. Journal of Bone and Mineral Research, 24, 522-533.
86. Tybjaerg-Hansen, A., Steffensen, R., Meinertz, H., Schnohr, P., & Nordestgaard, B.G. (1998). Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. New England Journal of Medicine, 338, 1577-1584.
87. Waddington, C.H. (1942). Canalization of development and the inheritance of acquired characteristics. Nature, 150, 563-565.
88. Warren, K.R., & Li, T.K. (2005). Genetic polymorphisms: Impact on the risk of fetal alcohol spectrum disorders. Birth Defects Research Part A: Clinical Molecular Teratology, 73, 195-203.
89. Weiss, K., & Terwilliger, J. (2000). How many diseases does it take to map a gene with SNPs? Nature Genetics, 26, 151-157.
90. Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
91. Wheatley, K., & Gray, R. (2004). Commentary: Mendelian randomization-An update on its use to evaluate allogeneic stem cell transplantation in leukaemia. International Journal of Epidemiology, 33, 15-17.
92. Wilkins, A.S. (1997). Canalization: A molecular genetic perspective. BioEssays, 19, 257-262.
93. Wolf, U. (1995). The genetic contribution to the phenotype. Human Genetics, 95, 127-148.
94. Youngman, L.D., Keavney, B.D., Palmer, A., Parish, S., Clark, S., Danesh, J., et al. (2000). Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: test of causality by 'Mendelian randomization'. Circulation, 102(Suppl. 2), 31-32.